Wegovy & Foundayo: Pill Revolution in Weight Loss Market

Novo Nordisks Wegovy pill and Eli Lillys Foundayo are revolutionizing the GLP-1 weight loss market, drawing in patients who prefer pills over shots. Telehealth platforms like LifeMD are experiencing a surge in new patients, with Wegovy alone attracting tens of thousands in four months. Novos aggressive marketing, including a Super Bowl shout from DJ Khaled, has boosted its sales. Lillys rollout is slower but shows strong organic buzz. Both companies are eyeing global expansion, with pills playing a significant but not decisive role in their pipeline strategy. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/85c2f9d0ebad52b5